Novartis AG is 250.0x more valuable than Zenas BioPharma, Inc. by market capitalization ($282.64 B vs $1.13 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ZBIO | NVS |
|---|---|---|
| Market cap | $1.13 B | $282.64 B |
| US-listed rank | #2544 | #47 |
| Revenue (latest FY) | $10.00M | - |
| Net income (latest FY) | -$377.74M | - |
| Net margin | -3777.4% | - |
| SEC filings | 166 | 947 |
Novartis AG is 250.0x more valuable than Zenas BioPharma, Inc. by market capitalization ($282.64 B vs $1.13 B).
Full pages: Zenas BioPharma, Inc. and Novartis AG, or browse the full rankings.